Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010

Clinical Infectious Diseases

Volumn 61, Issue 9, 2015, Pages 1403-1410

  Jones, Barbara E ^a   Jones, Makoto M ^b   Huttner, Benedikt ^e   Stoddard, Gregory ^b   Brown, Kevin Antoine ^b   Stevens, Vanessa W ^b   Greene, Tom ^b   Sauer, Brian ^b   Madaras Kelly, Karl ^c   Rubin, Michael ^b   Goetz, Matthew Bidwell ^d   Samore, Matthew ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c IDAHO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

antibiotic use; drug resistant pneumonia; HCAP; nosocomial pathogens; pneumonia

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DORIPENEM; DOXYCYCLINE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ADULT; AGED; ARTICLE; BLOOD CULTURE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; DRUG UTILIZATION; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; TRENDS; VETERAN;

ACINETOBACTER; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREVALENCE; PSEUDOMONAS AERUGINOSA; VETERANS;

EID: 84946811557     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ629     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. Pneumonia. Available at: http://www.cdc.gov/nchs/fastats/pneumonia.htm. Accessed 15 September 2014.
2. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013; 310:591-608.
3. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-Acquired, ventilator-Associated, and healthcare-Associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
4. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-Acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl 2):S27-72.
5. Facts about ORYX for hospitals (national hospital quality measures). The Joint Commission. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQuality Inits/Downloads/HospitalOverviewOfSpecs200512.pdf. Accessed 11 August 2015.
6. Centers for Medicare &Medicaid Services. Premier Hospital Quality Incentive Demonstration. Available at: https://www.cms.gov/hospitalqualityinits/35-hospitalpremier.asp. Accessed 15 September 2015.
7. Wunderink RG. Community-Acquired pneumonia versus healthcareassociated pneumonia. The returning pendulum. Am J Respir Crit Care Med 2013; 188:896-8.
8. Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. J Antimicrob Chemother 2013; 68:2393-9.
9. Jones M, Huttner B, Leecaster M, et al. Does universal active MRSA surveillance influence anti-MRSA antibiotic use? a retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010. J Antimicrob Chemother 2014; 69:3401-8.
10. Department of Veterans Affairs, Veterans Health Administration. 2010 VHA facility quality and safety report. Available at: http://www.va. gov/health/docs/HospitalReportCard2010.pdf. Accessed 6 August 2013.
11. US Department of Veterans Affairs. VA Informatics and Computing Infrastructure (VINCI). Available at: www.hsrd.research.va.gov/for-researchers/vinci. Accessed 19 February 2014.
12. Health information policy council; 1984 revision of the UniformHospital Discharge Data Set-HHS. Notice. Fed Regist 1985; 50:31038-40.
13. Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA 2012; 307:1405-13.
14. Rhunke GW, Coca-Perraillon M, Kitch BT, Cutler DM. Marked reduction in 30-day mortality among elderly patients with communityacquired pneumonia. Am J Med 2011; 124:171-8.e1.
15. Schneider R, Bagby J, Carlson R. Bar-code medication administration: a systems perspective. Am J Health Syst Pharm 2008; 65:2216, 8-9.
16. International Health Terminology Standards Development Organisation (IHTSDO). SNOMED CT: the global language of healthcare. Available at: http://www.ihtsdo.org/snomed-ct. Accessed 11 August 2015.
17. Glas AS, Lijmet JG, Prine MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56:1129-35.
18. Berger A, Edelsberg J, Oster G, Huang X, Weber DJ. Patterns of initial antibiotic therapy for community-Acquired pneumonia in US hospitals, 2000 to 2009. Am J Med Sci 2014; 347:347-56.
19. Kallen AJ, Mu Y, Bulens S, et al. Health care-Associated invasive MRSA infections, 2005-2008. JAMA 2010; 304:641-8.
20. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364:1419-30.
21. Moran. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-Acquired pneumonia. Clin Infect Dis 2012; 54:1126-33.
22. Smith SB, Ruhnke GW, Weiss CH, Waterer GW, Wunderink RG. Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011. JAMA Intern Med 2014; 174:1837-9.
23. Zilberberg MD, Shorr AF, Kollef MH, et al. Growth and geographic variation in hospitals with resistant infections in the US, 2000-2005. Emerg Infect Dis 2008; 14:1756-8.
24. Ewig S, Welte T, Torres A. Is healthcare-Associated pneumonia a distinct entity needing specific therapy? Curr Opin Infect Dis 2012; 25:166-75.
25. Grenier C, Pépin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-Associated and community-Acquired pneumonia. J Antimicrob Chemother 2011; 66:1617-24.
26. Rothberg MB, Zilberberg MD, Pekow PS, et al. Association of guidelinebased antimicrobial therapy and outcomes in healthcare-Associated pneumonia. J Antimicrob Chemother 2015; 70:1573-9.
27. Hsu JL, Siroka AM, Smith MW, et al. One-year outcomes of community-Acquired and healthcare-Associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis 2011; 15:e382-3287.
28. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-Associated pneumonia. Eur Respir J 2011; 38:878-87.
29. Kett DH, Cano E, Quartin AA, et al. Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators: implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011; 11:181-9.
30. Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS. Guideline-based antibiotics and mortality in healthcare-Associated pneumonia. J Gen Intern Med 2012; 27:845-52.
31. Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-Acquired and healthcare-Associated pneumonia. J Respir Crit Care Med 2013; 188:985-95.
32. Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-Acquired pneumonia. Ann the Am Thoracic Soc 2015; 12:153-60.
33. Chalmers JD, Salih W, Eqig S. Healthcare-Associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-Analysis. Clin Infect Dis 2014; 58:330-9.
34. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL. Predicting antibiotic resistance to community-Acquired pneumonia antibiotics in culture-positive patients with healthcare-Associated pneumonia. J Hosp Med 2012; 7:195-202.
35. Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drugresistant organisms in pneumonia: moving beyond the HCAP model. Respir Med 2015; 109:1-10.